Medical News

RSS

More insurers change how they pay medical providers

Commercial insurers are moving rapidly from the old system of paying health providers for every test or procedure they do toward payments based on the value rather than volume of services, according to a report by Catalyst for Payment Reform, a business coalition focused on health care costs.

30 Sep 2014

Women who accept their imperfections may experience more positive body image

Women who accept and tolerate their imperfections appear to have a more positive body image despite their body mass index (BMI) and are better able to handle personal disappointments and setbacks in their daily lives.

30 Sep 2014

Combination treatment prevents disease progression in patients with advanced melanoma

New data announced today has demonstrated that combinational treatment of cobimetinib with Zelboraf (vemurafenib), the first personalised medicine to extend life in the first-line setting for over 30 years, in patients with advanced melanoma (BRAFV600 mutation-positive) can prevent disease progression (progression-free survival; PFS) by 9.9 months compared to 6.2 months following treatment of vemurafenib alone.

30 Sep 2014

Majority of cancer survivors not financially prepared for cancer diagnosis, treatment

The majority (62%) of America's middle-income cancer survivors say they were not financially prepared for cancer diagnosis and treatment, according to a new study released by the Washington National Institute for Wellness Solutions.

30 Sep 2014

Anaphylaxis Campaign to hold special event to help prevent food business errors

The Anaphylaxis Campaign is set to hold a special event for the food industry on Tuesday 7th October 2014 to help prevent food business errors reaching crisis point.

30 Sep 2014

Titian Software launches Mosaic system for sample management efficiency

Titian Software has launched Mosaic 6.0, the latest version of its pre-eminent sample management software. Ideal for the management of compounds, biologicals and reagents, Mosaic 6.0 developments include more intuitive interfaces for ordering and inventory searching, and additional functions all designed to further streamline laboratory workflows, save valuable work-time and maximise the cost-effective use of resources.

30 Sep 2014

Synapse Biomedical completes enrollment in post-approval study of NeuRx DPS for ALS patients

Synapse Biomedical Inc. announced today it has completed the enrollment of the post-approval study of its NeuRx DPS System for ALS patients.

30 Sep 2014

Individuals can improve asthma symptoms by avoiding air pollution

People who suffer from asthma may think there's not a lot they can do to control their asthma besides properly taking medications and avoiding allergic triggers.

30 Sep 2014

U-M researchers describe new approach to discovering potential cancer treatments

Researchers at the University of Michigan have described a new approach to discovering potential cancer treatments that requires a fraction of the time needed for more traditional methods.

30 Sep 2014

Rwanda is Ebola free, says Ministry of Health

The Ministry of Health would like to inform Rwandans and all visitors to Rwanda that Rwanda is Ebola free. The lab results of the patient who was reported in the media this past week were negative for the Ebola Virus Disease.

30 Sep 2014

CMU's BrainHub initiative receives major boost from renowned Pittsburgh philanthropist

Just weeks after the launch of a global initiative to leverage its unique strengths to impact brain research, Carnegie Mellon University has received a major boost from renowned Pittsburgh philanthropist Henry L. Hillman in the form of a new $5 million gift to support CMU's BrainHub.

30 Sep 2014

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

Johnson & Johnson today announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash.

30 Sep 2014

AZD9291 shows median progression-free survival in patients with EGFRm T790M+ advanced NSCLC

Updated data from the ongoing AURA study of AZD9291 shows encouraging, although still immature, median progression free survival of 9.6 months (95% CI 8.3 to NC) in patients with epidermal growth factor receptor mutation positive (EGFRm) T790M+ advanced non-small cell lung cancer (NSCLC) who had disease progression following treatment with an EGFR tyrosine kinase inhibitor (EGFR TKI).

30 Sep 2014

GSK reports 45% survival rate in phase III study of Tafinlar in BRAF V600E mutant metastatic melanoma

GSK today announced updated results for Tafinlar (dabrafenib) from a planned analysis of the phase III BREAK-3 study in 250 patients with BRAF V600E mutant metastatic melanoma.

30 Sep 2014

States with higher rates of gun ownership experience higher incidence of non-stranger homicides

A new study led by a Boston University School of Public Health researcher has found that states with higher estimated rates of gun ownership experience a higher incidence of non-stranger firearms homicides - disputing the claim that gun ownership deters violent crime, its authors say.

30 Sep 2014

CNIO researchers discover new specific marker for cancer stem cells

Tumours are mosaics of cells that are morphologically and molecularly very different. In this cellular heterogeneity, it is calculated that only 1-2% of the tumour mass is made up of cancer stem cells, which over the past years have been suggested to be responsible for the origin of cancer and for the resistance to conventional chemical therapies.

30 Sep 2014

Innovative field device can assess, reduce risk of hamstring injury

Elite sporting stars can assess and reduce their risk of a hamstring injury thanks to a breakthrough made by QUT researchers.

30 Sep 2014

Luminex gets FDA approval to add three new targets to xTAG Gastrointestinal Pathogen Panel

Luminex Corporation today announced it has received U.S. FDA clearance to add three new targets to its xTAG Gastrointestinal Pathogen Panel (GPP). The targets include Adenovirus 40/41, Entamoeba histolytica and Vibrio cholerae.

From Luminex 30 Sep 2014

Moberg receives CE Mark approval for CNS Monitor

Moberg has received CE Mark approval for the CNS Monitor, a medical device used for advanced monitoring of neurological intensive care patients. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.

30 Sep 2014

DNA Diagnostics Center launches new Paternity Test Kit

DNA Diagnostics Center, the world's largest DNA Paternity Testing Company, announces the launch of a new Paternity Test Kit to be sold in national retail stores, expanding the company's reach in the marketplace.

30 Sep 2014

Medical News

More insurers change how they pay medical providers

Women who accept their imperfections may experience more positive body image

Combination treatment prevents disease progression in patients with advanced melanoma

Majority of cancer survivors not financially prepared for cancer diagnosis, treatment

Anaphylaxis Campaign to hold special event to help prevent food business errors

Titian Software launches Mosaic system for sample management efficiency

Synapse Biomedical completes enrollment in post-approval study of NeuRx DPS for ALS patients

Individuals can improve asthma symptoms by avoiding air pollution

U-M researchers describe new approach to discovering potential cancer treatments

Rwanda is Ebola free, says Ministry of Health

CMU's BrainHub initiative receives major boost from renowned Pittsburgh philanthropist

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

AZD9291 shows median progression-free survival in patients with EGFRm T790M+ advanced NSCLC

GSK reports 45% survival rate in phase III study of Tafinlar in BRAF V600E mutant metastatic melanoma

States with higher rates of gun ownership experience higher incidence of non-stranger homicides

CNIO researchers discover new specific marker for cancer stem cells

Innovative field device can assess, reduce risk of hamstring injury

Luminex gets FDA approval to add three new targets to xTAG Gastrointestinal Pathogen Panel

Moberg receives CE Mark approval for CNS Monitor

DNA Diagnostics Center launches new Paternity Test Kit

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News